✦ LIBER ✦

Two-year clinical outcomes of different drug-eluting stents with different polymer coating strategies in coronary artery heart disease: A multi-centre, randomised, controlled clinical trial

✍ Scribed by Zhang, Yue; Shen, Junle; Li, Zhifeng; Zhu, Aidong; Yuan, Yuelong; Yue, Ruihua; Yuan, Jia; Yin, Yuehui; She, Qiang; Chen, Yunqing

Book ID: 122098809
Publisher: Elsevier Science
Year: 2013
Tongue: English
Weight: 545 KB
Volume: 168
Category: Article
ISSN: 0167-5273
DOI: 10.1016/j.ijcard.2013.03.034

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Long-term clinical outcomes of biodegrad

Long-term clinical outcomes of biodegradable polymer biolimus-eluting stents versus durable polymer sirolimus-eluting stents in patients with coronary artery disease (LEADERS): 4 year follow-up of a randomised non-inferiority trial

✍ Giulio G Stefanini; Bindu Kalesan; Patrick W Serruys; Dik Heg; Pawel Buszman; Ax 📂 Article 📅 2011 🏛 The Lancet 🌐 English ⚖ 286 KB

One-Year Clinical Outcome of a Randomize

One-Year Clinical Outcome of a Randomized Trial of Polymer-Free Paclitaxel-Eluting Stents Versus Biodegradable Polymer-Based Rapamycin-Eluting Stents in Patients with Coronary Heart Disease

✍ LAN ZHANG; JIA YUAN; GAN LIU; JIN-PENG ZHONG; YUE-HUI YIN; QIANG SH 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 498 KB

A bioresorbable everolimus-eluting scaff

A bioresorbable everolimus-eluting scaffold versus a metallic everolimus-eluting stent for ischaemic heart disease caused by de-novo native coronary artery lesions (ABSORB II): an interim 1-year analysis of clinical and procedural secondary outcomes from a randomised controlled trial

✍ Serruys, Patrick W; Chevalier, Bernard; Dudek, Dariusz; Cequier, Angel; Carrié, 📂 Article 📅 2015 🏛 The Lancet 🌐 English ⚖ 411 KB

Late-Term Clinical Outcomes With Zotarol

Late-Term Clinical Outcomes With Zotarolimus- and Sirolimus-Eluting Stents: 5-Year Follow-Up of the ENDEAVOR III (A Randomized Controlled Trial of the Medtronic Endeavor Drug [ABT-578] Eluting Coronary Stent System Versus the Cypher Sirolimus-Eluting Coronary Stent System in De Novo Native Coronary Artery Lesions)

✍ David E. Kandzari; Laura Mauri; Jeffrey J. Popma; Mark A. Turco; Paul A. Gurbel; 📂 Article 📅 2011 🏛 American College of Cardiology 🌐 English ⚖ 704 KB